Model
Edge
Halozyme Therapeutics, Inc.
0001902866
Filing Type
4
Filing Date
6/12/2025
Updated
6/13/25, 3:33 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership